BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Fujita KI, Kubota Y, Ishida H, Sasaki Y. Irinotecan, a key chemotherapeutic drug for metastatic colorectal cancer. World J Gastroenterol 2015; 21(43): 12234-12248 [PMID: 26604633 DOI: 10.3748/wjg.v21.i43.12234]
URL: https://www.wjgnet.com/1007-9327/full/v21/i43/12234.htm
Number Citing Articles
1
Peng Zhu, Zhi Ye, Dong Guo, Zongping Xiong, Shiqiong Huang, Jun Guo, Wei Zhang, James E. Polli, Honghao Zhou, Qing Li, Yan Shu. Irinotecan Alters the Disposition of Morphine Via Inhibition of Organic Cation Transporter 1 (OCT1) and 2 (OCT2)Pharmaceutical Research 2018; 35(12) doi: 10.1007/s11095-018-2526-y
2
A.L. Zakharenko, O.A. Luzina, D.N. Sokolov, V.I. Kaledin, V.P. Nikolin, N.A. Popova, J. Patel, O.D. Zakharova, A.A. Chepanova, A. Zafar, J. Reynisson, E. Leung, I.K.H. Leung, K.P. Volcho, N.F. Salakhutdinov, O.I. Lavrik. Novel tyrosyl-DNA phosphodiesterase 1 inhibitors enhance the therapeutic impact of topoteсan on in vivo tumor modelsEuropean Journal of Medicinal Chemistry 2019; 161: 581 doi: 10.1016/j.ejmech.2018.10.055
3
Orkun Sarioglu, Ahmet Ergin Capar, Umit Belet. Colon Polyps and Colorectal Cancer2021; : 629 doi: 10.1007/978-3-030-57273-0_31
4
Suélen Karine Sartori, Marisa Alves Nogueira Diaz, Gaspar Diaz-Muñoz. Lactones: Classification, synthesis, biological activities, and industrial applicationsTetrahedron 2021; 84: 132001 doi: 10.1016/j.tet.2021.132001
5
Kei Irie, Akira Okada, Yoshio Masuda, Keizo Fukushima, Nobuyuki Sugioka, Chiyuki Okuda, Akito Hata, Reiko Kaji, Yutaka Okada, Nobuyuki Katakami, Shoji Fukushima. Assessment of exposure risk of irinotecan and its active metabolite, SN-38, through perspiration during chemotherapyJournal of Oncology Pharmacy Practice 2019; 25(4): 865 doi: 10.1177/1078155218769136
6
Qiongna Dong, Bizhi Shi, Min Zhou, Huiping Gao, Xiaoying Luo, Zonghai Li, Hua Jiang. Growth suppression of colorectal cancer expressing S492R EGFR by monoclonal antibody CH12Frontiers of Medicine 2019; 13(1): 83 doi: 10.1007/s11684-019-0682-z
7
Ram P. Das, Sarjak Chakravarti, Snehal S. Patel, Pooja Lakhamje, Murari Gurjar, Vikram Gota, Beena G. Singh, Amit Kunwar. Tuning the pharmacokinetics and efficacy of irinotecan (IRI) loaded gelatin nanoparticles through folate conjugationInternational Journal of Pharmaceutics 2020; 586: 119522 doi: 10.1016/j.ijpharm.2020.119522
8
Da-Hyun Kim, Seul Lee, Hyeok Gu Kang, Hyun-Woo Park, Han-Woong Lee, Dongin Kim, Dong-Hoon Yoem, Jin-Hyung Ahn, Eunsin Ha, Weon-Kyoo You, Sang Hoon Lee, Seok-Jun Kim, Kyung-Hee Chun. Synergistic antitumor activity of a DLL4/VEGF bispecific therapeutic antibody in combination with irinotecan in gastric cancerBMB Reports 2020; 53(10): 533 doi: 10.5483/BMBRep.2020.53.10.103
9
Zhuo-Xun Wu, Yuqi Yang, Leli Zeng, Harsh Patel, Letao Bo, Lusheng Lin, Zhe-Sheng Chen. Establishment and Characterization of an Irinotecan-Resistant Human Colon Cancer Cell LineFrontiers in Oncology 2021; 10 doi: 10.3389/fonc.2020.624954
10
Erika Cecchin, Elena De Mattia, Fabrizio Ecca, Giuseppe Toffoli. Host genetic profiling to increase drug safety in colorectal cancer from discovery to implementationDrug Resistance Updates 2018; 39: 18 doi: 10.1016/j.drup.2018.07.001
11
Eman E. Nasr, Amany S. Mostafa, Magda A. A. El‐Sayed, Mohammed A. M. Massoud. Design, synthesis, and docking study of new quinoline derivatives as antitumor agentsArchiv der Pharmazie 2019; 352(7): 1800355 doi: 10.1002/ardp.201800355
12
Andrea Idili, Netzahualcóyotl Arroyo-Currás, Kyle L. Ploense, Andrew T. Csordas, Masayasu Kuwahara, Tod E. Kippin, Kevin W. Plaxco. Seconds-resolved pharmacokinetic measurements of the chemotherapeutic irinotecan in situ in the living bodyChemical Science 2019; 10(35): 8164 doi: 10.1039/C9SC01495K
13
Shuqin Xing, Yafei Wang, Kaiwen Hu, Fen Wang, Tao Sun, Quanwang Li. WGCNA reveals key gene modules regulated by the combined treatment of colon cancer with PHY906 and CPT11Bioscience Reports 2020; 40(9) doi: 10.1042/BSR20200935
14
Nikolaos Tsakiris, Malamatenia Papavasileiou, Elia Bozzato, Alessandra Lopes, Arnaud M. Vigneron, Véronique Préat. Combinational drug-loaded lipid nanocapsules for the treatment of cancerInternational Journal of Pharmaceutics 2019; 569: 118588 doi: 10.1016/j.ijpharm.2019.118588
15
Nevenka Kopjar, Nino Fuchs, Irena Brčić Karačonji, Suzana Žunec, Anja Katić, Goran Kozina, Ana Lucić Vrdoljak. High Doses of Δ9-Tetrahydrocannabinol Might Impair Irinotecan Chemotherapy: A Review of Potentially Harmful InteractionsClinical Drug Investigation 2020; 40(9): 775 doi: 10.1007/s40261-020-00954-y
16
Xiang Li, Ting Liang, Si‐Si Chen, Meng Wang, Rui Wang, Kai Li, Ji‐Chang Wang, Chong‐Wen Xu, Ning Du, Sida Qin, Hong Ren. Matrine suppression of self‐renewal was dependent on regulation of LIN28A/Let‐7 pathway in breast cancer stem cellsJournal of Cellular Biochemistry 2020; 121(3): 2139 doi: 10.1002/jcb.29396
17
Thaise Boeing, Priscila Souza, Silvia Speca, Lincon Bordignon Somensi, Luisa Nathália Bolda Mariano, Benhur Judah Cury, Mariana Ferreira dos Anjos, Nara Lins Meira Quintão, Laurent Dubuqoy, Pierre Desreumax, Luisa Mota Silva, Sérgio Faloni Andrade. Luteolin prevents irinotecan‐induced intestinal mucositis in mice through antioxidant and anti‐inflammatory propertiesBritish Journal of Pharmacology 2020; 177(10): 2393 doi: 10.1111/bph.14987
18
A. I. Fraguas-Sánchez, C. Martín-Sabroso, A. Fernández-Carballido, A. I. Torres-Suárez. Current status of nanomedicine in the chemotherapy of breast cancerCancer Chemotherapy and Pharmacology 2019; 84(4): 689 doi: 10.1007/s00280-019-03910-6
19
Takashi Higuchi, Kentaro Miyake, Hiromichi Oshiro, Norihiko Sugisawa, Norio Yamamoto, Katsuhiro Hayashi, Hiroaki Kimura, Shinji Miwa, Kentaro Igarashi, Sant P. Chawla, Michael Bouvet, Shree Ram Singh, Hiroyuki Tsuchiya, Robert M. Hoffman. Trabectedin and irinotecan combination regresses a cisplatinum-resistant osteosarcoma in a patient-derived orthotopic xenograft nude-mouse modelBiochemical and Biophysical Research Communications 2019; 513(2): 326 doi: 10.1016/j.bbrc.2019.03.191
20
Iera Hernandez-Unzueta, Aitor Benedicto, Elvira Olaso, Eduardo Sanz, Cristina Viera, Beatriz Arteta, Joana Márquez. Ocoxin oral solution® as a complement to irinotecan chemotherapy in the metastatic progression of colorectal cancer to the liverOncology Letters 2017; 13(6): 4002 doi: 10.3892/ol.2017.6016
21
Jiali Dai, Yuetong Chen, Yang Gong, Jingsun Wei, Xiaowen Cui, Hualin Yu, Wenjing Zhao, Dongying Gu, Jinfei Chen. The efficacy and safety of irinotecan ± bevacizumab compared with oxaliplatin ± bevacizumab for metastatic colorectal cancerMedicine 2019; 98(39): e17384 doi: 10.1097/MD.0000000000017384
22
Elena De Mattia, Erika Cecchin, Marcella Montico, Adrien Labriet, Chantal Guillemette, Eva Dreussi, Rossana Roncato, Alessia Bignucolo, Angela Buonadonna, Mario D’Andrea, Luigi Coppola, Sara Lonardi, Eric Lévesque, Derek Jonker, Félix Couture, Giuseppe Toffoli. Association of STAT-3 rs1053004 and VDR rs11574077 With FOLFIRI-Related Gastrointestinal Toxicity in Metastatic Colorectal Cancer PatientsFrontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.00367
23
Danjun Wu, Lixi Zhu, Yi Li, Huiying Wang, Shumin Xu, Xueling Zhang, Rui Wu, Gensheng Yang. Superparamagnetic chitosan nanocomplexes for colorectal tumor-targeted delivery of irinotecanInternational Journal of Pharmaceutics 2020; 584: 119394 doi: 10.1016/j.ijpharm.2020.119394
24
Yifeng Qin, An Kang, Guisheng Zhou, Huan Wang, Wei Wei, Yujie Cao, Yanyan Chen, Jing Wang, Yajun Shi, Yuping Tang, Jianqin Jiang. Carboxylesterase and UDP-glucuronosyltransferases mediated metabolism of irinotecan: In vitro and in vivo insights from quantitative ultra-performance liquid chromatography-mass spectrometry analysisBiomedical Chromatography 2018; 32(10): e4320 doi: 10.1002/bmc.4320
25
Adrien Labriet, Éric Lévesque, Erika Cecchin, Elena De Mattia, Lyne Villeneuve, Michèle Rouleau, Derek Jonker, Félix Couture, David Simonyan, Eric P. Allain, Angela Buonadonna, Mario D’Andrea, Giuseppe Toffoli, Chantal Guillemette. Germline variability and tumor expression level of ribosomal protein gene RPL28 are associated with survival of metastatic colorectal cancer patientsScientific Reports 2019; 9(1) doi: 10.1038/s41598-019-49477-3
26
Reetu Mukherji, John Marshall, Andreas Seeber. Genomic Alterations and Their Implications on Survival in Nonmetastatic Colorectal Cancer: Status Quo and Future PerspectivesCancers 2020; 12(8): 2001 doi: 10.3390/cancers12082001
27
Ayako Tsuboya, Yutaro Kubota, Hiroo Ishida, Ryotaro Ohkuma, Tomoyuki Ishiguro, Yuya Hirasawa, Hirotsugu Ariizumi, Takuya Tsunoda, Yasutsuna Sasaki, Natsumi Matsumoto, Yusuke Kondo, Yukana Tomoda, Hiroyuki Kusuhara, Ken-ichi Fujita. Minimal contribution of the hepatic uptake transporter OATP1B1 to the inter-individual variability in SN-38 pharmacokinetics in cancer patients without severe renal failureCancer Chemotherapy and Pharmacology 2021;  doi: 10.1007/s00280-021-04314-1
28
Shan Lu, Obinna N. Obianom, Yong Ai. Novel hybrids derived from aspirin and chalcones potently suppress colorectal cancer in vitro and in vivoMedChemComm 2018; 9(10): 1722 doi: 10.1039/C8MD00284C
29
Hiroto Fujita, Yuka Kataoka, Masayasu Kuwahara. Bifunctional Aptamer Drug Carrier Enabling Selective and Efficient Incorporation of an Approved Anticancer Drug Irinotecan to Fibrin GelsApplied Sciences 2020; 10(23): 8755 doi: 10.3390/app10238755
30
Dimitra-Ioanna Lampropoulou, Gerasimos Aravantinos, Hector Katifelis, Foivos Lazaris, Konstantinos Laschos, Theodosios Theodosopoulos, Christos Papadimitriou, Maria Gazouli. Long non-coding RNA polymorphisms and prediction of response to chemotherapy based on irinotecan in patients with metastatic colorectal cancerCancer Biomarkers 2019; 25(2): 213 doi: 10.3233/CBM-182383
31
Elena De Mattia, Erika Cecchin, Rossana Roncato, Giuseppe Toffoli. Pregnane X receptor, constitutive androstane receptor and hepatocyte nuclear factors as emerging players in cancer precision medicinePharmacogenomics 2016; 17(14): 1547 doi: 10.2217/pgs-2016-0095
32
Sergio C. Chai, William C. Wright, Taosheng Chen. Strategies for developing pregnane X receptor antagonists: Implications from metabolism to cancerMedicinal Research Reviews 2020; 40(3): 1061 doi: 10.1002/med.21648
33
The Hong Phong Nguyen, V. Bharath Kumar, Vinoth Kumar Ponnusamy, Thi Thu Thao Mai, Phuong Tran Nhat, Kathirvel Brindhadevi, Arivalagan Pugazhendhi. Phytochemicals intended for anticancer effects at preclinical levels to clinical practice: Assessment of formulations at nanoscale for non-small cell lung cancer (NSCLC) therapyProcess Biochemistry 2021; 104: 55 doi: 10.1016/j.procbio.2021.02.004
34
Yong-Hee Cho, Eun Ji Ro, Jeong-Su Yoon, Tomohiro Mizutani, Dong-Woo Kang, Jong-Chan Park, Tae Il Kim, Hans Clevers, Kang-Yell Choi. 5-FU promotes stemness of colorectal cancer via p53-mediated WNT/β-catenin pathway activationNature Communications 2020; 11(1) doi: 10.1038/s41467-020-19173-2
35
Fabio Gosetti, Masho Hilawie Belay, Emilio Marengo, Elisa Robotti. Development and validation of a UHPLC-MS/MS method for the identification of irinotecan photodegradation products in water samplesEnvironmental Pollution 2020; 256: 113370 doi: 10.1016/j.envpol.2019.113370
36
Yan-Yan Zhu, Qiong Jin, Shan-Shan Chen, Dan-Ni Jin, Zhao-Jie Wang, Ying-Jie He, Hui-Cheng Chen, Yun-Li Zhao, Li-Xing Zhao, Zhi Dai, Xiao-Dong Luo. Neothalfine, a potent natural anti-tumor agent against metastatic colorectal cancer and its primary mechanismBioorganic & Medicinal Chemistry 2021; 29: 115849 doi: 10.1016/j.bmc.2020.115849
37
Maria M. Lukina, Marina A. Sirotkina, Anna G. Orlova, Varvara V. Dudenkova, Anastasia D. Komarova, Anton A. Plekhanov, Ludmila B. Snopova, Elena V. Zagaynova, Dmitri B. Papkovsky, Vladislav I. Shcheslavskiy, Marina V. Shirmanova. Effects of Irinotecan on Tumor Vasculature and Oxygenation: An in vivo Study on Colorectal Cancer ModelIEEE Journal of Selected Topics in Quantum Electronics 2021; 27(4): 1 doi: 10.1109/JSTQE.2020.3047518
38
Rick-Léonid Ngoua Meye Misso, Fleury Augustin Nsole Biteghe, Cédric Sima Obiang, Joseph-Privat Ondo, Nan Gao, Miguel Cervantes-Cervantes, Guillaume Vignaux, Aurelia Vergeade, Jean Engohang-Ndong, Hugue Ella Mendene, Barthelemy Mabika, Félix Ovono Abessolo, Louis-Clement Obame Engonga, Jean De La Croix Ndong. Effect of aqueous extracts of Ficus vogeliana Miq and Tieghemella africana Pierre in 7,12-Dimethylbenz(a)anthracene -induced skin cancer in ratsJournal of Ethnopharmacology 2020; 263: 113244 doi: 10.1016/j.jep.2020.113244
39
Ruipu Sun, Ying Ying, Zhimin Tang, Ting Liu, Fuli Shi, Huixia Li, Taichen Guo, Shibo Huang, Ren Lai. The Emerging Role of the SLCO1B3 Protein in Cancer ResistanceProtein & Peptide Letters 2019; 27(1): 17 doi: 10.2174/0929866526666190926154248
40
Tahia K. Mohamed, Rasha Z. Batran, Samia A. Elseginy, Mamdouh M. Ali, Abeer E. Mahmoud. Synthesis, anticancer effect and molecular modeling of new thiazolylpyrazolyl coumarin derivatives targeting VEGFR-2 kinase and inducing cell cycle arrest and apoptosisBioorganic Chemistry 2019; 85: 253 doi: 10.1016/j.bioorg.2018.12.040
41
Boah Lee, Jeong A. Min, Abdullateef Nashed, Sang-Ok Lee, Jae Cheal Yoo, Seung-Wook Chi, Gwan-Su Yi. A novel mechanism of irinotecan targeting MDM2 and Bcl-xLBiochemical and Biophysical Research Communications 2019; 514(2): 518 doi: 10.1016/j.bbrc.2019.04.009
42
Riccardo Rampado, Sara Crotti, Paolo Caliceti, Salvatore Pucciarelli, Marco Agostini. Nanovectors Design for Theranostic Applications in Colorectal CancerJournal of Oncology 2019; 2019: 1 doi: 10.1155/2019/2740923
43
Jing-Fang Zhang, Wan-Chao Zhong, Yan-Cheng Li, Yun-Qing Song, Gui-Yang Xia, Gui-Hua Tian, Guang-Bo Ge, Sheng Lin. Bioactivity-Guided Discovery of Human Carboxylesterase Inhibitors from the Roots of Paeonia lactifloraJournal of Natural Products 2020; 83(10): 2940 doi: 10.1021/acs.jnatprod.0c00464
44
Sára Lenárt, Peter Lenárt, Jan Šmarda, Ján Remšík, Karel Souček, Petr Beneš. Trop2: Jack of All Trades, Master of NoneCancers 2020; 12(11): 3328 doi: 10.3390/cancers12113328
45
Katy Vaillancourt, Amel Ben Lagha, Daniel Grenier. A green tea extract and epigallocatechin-3-gallate attenuate the deleterious effects of irinotecan in an oral epithelial cell modelArchives of Oral Biology 2021; 126: 105135 doi: 10.1016/j.archoralbio.2021.105135
46
Jia-Nan Li, Yun-Feng Cao, Rong-Rong He, Guang-Bo Ge, Bin Guo, Jing-Jing Wu. Evidence for Shikonin acting as an active inhibitor of human carboxylesterases 2: Implications for herb-drug combinationPhytotherapy Research 2018; 32(7): 1311 doi: 10.1002/ptr.6062
47
Anne Kauffels, Marie Kitzmüller, Andrea Gruber, Hannah Nowack, Hanibal Bohnenberger, Melanie Spitzner, Anja Kuthning, Thilo Sprenger, Martin Czejka, Michael Ghadimi, Jens Sperling. Hepatic arterial infusion of irinotecan and EmboCept® S results in high tumor concentration of SN-38 in a rat model of colorectal liver metastasesClinical & Experimental Metastasis 2019; 36(1): 57 doi: 10.1007/s10585-019-09954-5
48
Darren C. Phillips, Fritz G. Buchanan, Dong Cheng, Larry R. Solomon, Yu Xiao, John Xue, Stephen K. Tahir, Morey L. Smith, Haichao Zhang, Deborah Widomski, Vivek C. Abraham, Nan Xu, Zhihong Liu, Li Zhou, Enrico DiGiammarino, Xin Lu, Nandini Rudra-Ganguly, Bruce Trela, Susan E. Morgan-Lappe. Hexavalent TRAIL Fusion Protein Eftozanermin Alfa Optimally Clusters Apoptosis-Inducing TRAIL Receptors to Induce On-Target Antitumor Activity in Solid TumorsCancer Research 2021; 81(12): 3402 doi: 10.1158/0008-5472.CAN-20-2178
49
Tatyana Khomenko, Alexandra Zakharenko, Tatyana Odarchenko, Homayon John Arabshahi, Victoriya Sannikova, Olga Zakharova, Dina Korchagina, Jóhannes Reynisson, Konstantin Volcho, Nariman Salakhutdinov, Olga Lavrik. New inhibitors of tyrosyl-DNA phosphodiesterase I (Tdp 1) combining 7-hydroxycoumarin and monoterpenoid moietiesBioorganic & Medicinal Chemistry 2016; 24(21): 5573 doi: 10.1016/j.bmc.2016.09.016
50
Jonathan P. Evans, Boleslaw K. Winiarski, Paul A. Sutton, Robert P. Jones, Lorenzo Ressel, Carrie A. Duckworth, D. Mark Pritchard, Zhi-Xiu Lin, Vicky L. Fretwell, Elizabeth M. Tweedle, Eithne Costello, Christopher E. Goldring, Ian M. Copple, B. Kevin Park, Daniel H. Palmer, Neil R. Kitteringham. The Nrf2 inhibitor brusatol is a potent antitumour agent in an orthotopic mouse model of colorectal cancerOncotarget 2018; 9(43): 27104 doi: 10.18632/oncotarget.25497
51
Wen Luo, Qingan Liu, Xinwen Chen, Haijun Liu, Bin Quan, Jinli Lu, Ke Zhang, Xiangling Wang, Junyan Liu. FXYD6 Regulates Chemosensitivity by Mediating the Expression of Na+/K+-ATPase α1 and Affecting Cell Autophagy and Apoptosis in Colorectal CancerBioMed Research International 2021; 2021: 1 doi: 10.1155/2021/9986376
52
Thaise Boeing, Marcelo Biondaro Gois, Priscila de Souza, Lincon Bordignon Somensi, Débora de Mello Gonçales Sant´Ana, Luisa Mota da Silva. Irinotecan-induced intestinal mucositis in mice: a histopathological studyCancer Chemotherapy and Pharmacology 2021; 87(3): 327 doi: 10.1007/s00280-020-04186-x
53
Takeshi Kinoshita, Hajime Higuchi, Ayano- Kabashima-, Gen Sakai, Yasuo Hamamoto, Hiromasa Takaishi, Takanori Kanai. Analysis of Sensitivity and Cell Death Pathways Mediated by Anti-cancer Drugs Using Three-dimensional Culture SystemInternational Journal of Cancer Research 2017; 14(1): 1 doi: 10.3923/ijcr.2018.1.12
54
Mateusz Kciuk, Beata Marciniak, Renata Kontek. Irinotecan—Still an Important Player in Cancer Chemotherapy: A Comprehensive OverviewInternational Journal of Molecular Sciences 2020; 21(14): 4919 doi: 10.3390/ijms21144919
55
Madhusmita Dhupal, Devasish Chowdhury. <p>Phytochemical-Based Nanomedicine for Advanced Cancer Theranostics: Perspectives on Clinical Trials to Clinical Use</p>International Journal of Nanomedicine 2020; : 9125 doi: 10.2147/IJN.S259628
56
Carolina de la Guardia, David Stephens, Hang Dang, Mario Quijada, Oleg Larionov, Ricardo Lleonart. Antiviral Activity of Novel Quinoline Derivatives against Dengue Virus Serotype 2Molecules 2018; 23(3): 672 doi: 10.3390/molecules23030672
57
Gang Tang, Linyu Zhang. Update on Strategies of Probiotics for the Prevention and Treatment of Colorectal CancerNutrition and Cancer 2020; : 1 doi: 10.1080/01635581.2020.1865420
58
Jinhee Kim, Hye-Youn Kim, Suntaek Hong, Sarah Shin, Young Ah Kim, No Soo Kim, Ok-Sun Bang. A new herbal formula BP10A exerted an antitumor effect and enhanced anticancer effect of irinotecan and oxaliplatin in the colon cancer PDTX modelBiomedicine & Pharmacotherapy 2019; 116: 108987 doi: 10.1016/j.biopha.2019.108987
59
Alexandra Zakharenko, Olga Luzina, Olga Koval, Dmitry Nilov, Irina Gushchina, Nadezhda Dyrkheeva, Vytas Švedas, Nariman Salakhutdinov, Olga Lavrik. Tyrosyl-DNA Phosphodiesterase 1 Inhibitors: Usnic Acid Enamines Enhance the Cytotoxic Effect of CamptothecinJournal of Natural Products 2016; 79(11): 2961 doi: 10.1021/acs.jnatprod.6b00979
60
Madhumita Roy, Amitava Datta. Cancer Genetics and Therapeutics2019; : 165 doi: 10.1007/978-981-13-9471-3_7
61
Ayako Tsuboya, Ken-ichi Fujita, Yutaro Kubota, Hiroo Ishida, Iori Taki-Takemoto, Daisuke Kamei, Shinichi Iwai, Yasutsuna Sasaki. Coadministration of cytotoxic chemotherapeutic agents with irinotecan is a risk factor for irinotecan-induced cholinergic syndrome in Japanese patients with cancerInternational Journal of Clinical Oncology 2019; 24(2): 222 doi: 10.1007/s10147-018-1347-7
62
Susan J. Zunino, David H. Storms. Resveratrol-3-O-glucuronide and resveratrol-4′-O-glucuronide reduce DNA strand breakage but not apoptosis in Jurkat T cells treated with camptothecinOncology Letters 2017; 14(2): 2517 doi: 10.3892/ol.2017.6392
63
Chen Zhang, Catherine Hemmert, Heinz Gornitzka, Olivier Cuvillier, Ming Zhang, Raymond Wai-Yin Sun. Cationic and Neutral N -Heterocyclic Carbene Gold(I) Complexes: Cytotoxicity, NCI-60 Screening, Cellular Uptake, Inhibition of Mammalian Thioredoxin Reductase, and Reactive Oxygen Species FormationChemMedChem 2018; 13(12): 1218 doi: 10.1002/cmdc.201800181
64
Qiao Yijie, Wang Xuejun, Xin Yuanyao, Nian Yongqiong, Yang Jianxin, Duan Yabin, Li Xiangyang. Effect of X‐ray irradiation on pharmacokinetics of irinotecan hydrochloride and expression of CES 1 and CYP 3A1 in rats Fundamental & Clinical Pharmacology 2019; 33(5): 558 doi: 10.1111/fcp.12456
65
Hiu Ting Chan, Yoon Ming Chin, Siew-Kee Low. The Roles of Common Variation and Somatic Mutation in Cancer PharmacogenomicsOncology and Therapy 2019; 7(1): 1 doi: 10.1007/s40487-018-0090-6
66
Abdel B. Halim. Biomarkers, Diagnostics and Precision Medicine in the Drug Industry2019; : 41 doi: 10.1016/B978-0-12-816121-0.00003-9
67
Jin Wang, Li Shao, Chong-Zhi Wang, Hong-Hao Zhou, Chun-Su Yuan, Wei-Hua Huang. Synergetic Inhibition of Human Colorectal Cancer Cells by Combining Polyyne-Enriched Fraction from Oplopanax elatus and IrinotecanNutrition and Cancer 2019; 71(3): 472 doi: 10.1080/01635581.2018.1516788
68
Lucia Scarabel, Marica Garziera, Sara Fortuna, Fioretta Asaro, Giuseppe Toffoli, Silvano Geremia. Soluble HLA-G expression levels and HLA-G/irinotecan association in metastatic colorectal cancer treated with irinotecan-based strategyScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-65424-z
69
Octav Ginghină, Ariana Hudiță, Cătălin Zaharia, Aristidis Tsatsakis, Yaroslav Mezhuev, Marieta Costache, Bianca Gălățeanu. Current Landscape in Organic Nanosized Materials Advances for Improved Management of Colorectal Cancer PatientsMaterials 2021; 14(9): 2440 doi: 10.3390/ma14092440
70
Magdalena Szaryńska, Agata Olejniczak, Jarosław Kobiela, Piotr Spychalski, Zbigniew Kmieć. Therapeutic strategies against cancer stem cells in human colorectal cancer (Review)Oncology Letters 2017;  doi: 10.3892/ol.2017.7261
71
Tianwei Xu, Mengwei Wang, Lihua Jiang, Li Ma, Li Wan, Qinnan Chen, Chenchen Wei, Zhaoxia Wang. CircRNAs in anticancer drug resistance: recent advances and future potentialMolecular Cancer 2020; 19(1) doi: 10.1186/s12943-020-01240-3
72
Beata Naumczuk, Jerzy Sitkowski, Wojciech Bocian, Magdalena Stolarska, Elżbieta Bednarek, Lech Kozerski. A NMR study of binding the metabolite of SN38 derivatives to a model nicked DNA decamer mimicking target of Topo I inhibitorsBioorganic Chemistry 2021; 107: 104631 doi: 10.1016/j.bioorg.2021.104631
73
Ana Lucić Vrdoljak, Nino Fuchs, Anja Mikolić, Suzana Žunec, Irena Brčić Karačonji, Andreja Jurič, Ljerka Prester, Vedran Micek, Marijana Neuberg, Samir Čanović, Gordan Mršić, Nevenka Kopjar. Irinotecan and Δ9-Tetrahydrocannabinol Interactions in Rat Liver: A Preliminary Evaluation Using Biochemical and Genotoxicity MarkersMolecules 2018; 23(6): 1332 doi: 10.3390/molecules23061332
74
Zhiyu Wang, Aimin Zang, Yaning Wei, Lin An, Dan Hong, Yan Shi, Jingnan Zhang, Shenyong Su, Guotao Fang. <p>Hyaluronic Acid Capped, Irinotecan and Gene Co-Loaded Lipid-Polymer Hybrid Nanocarrier-Based Combination Therapy Platform for Colorectal Cancer</p>Drug Design, Development and Therapy 2020; : 1095 doi: 10.2147/DDDT.S230306
75
Myriam Mérarchi, Gautam Sethi, Lu Fan, Srishti Mishra, Frank Arfuso, Kwang Ahn. Molecular Targets Modulated by Fangchinoline in Tumor Cells and Preclinical ModelsMolecules 2018; 23(10): 2538 doi: 10.3390/molecules23102538
76
Philip Emmerich, Linda Clipson, Dustin A. Deming. Resistance Mechanisms to Colorectal Cancer Therapeutics and the Clinical ImplicationsCurrent Colorectal Cancer Reports 2017; 13(4): 334 doi: 10.1007/s11888-017-0374-5
77
Xue Zhang, Jia-Fu Yin, Jiao Zhang, Shu-Jia Kong, Hong-Yin Zhang, Xue-Mei Chen. UGT1A1*6 polymorphisms are correlated with irinotecan-induced neutropenia: a systematic review and meta-analysisCancer Chemotherapy and Pharmacology 2017; 80(1): 135 doi: 10.1007/s00280-017-3344-3
78
Mohini Singh, Chitra Venugopal, Tomas Tokar, Nicole McFarlane, Minomi K. Subapanditha, Maleeha Qazi, David Bakhshinyan, Parvez Vora, Naresh K. Murty, Igor Jurisica, Sheila K. Singh. Therapeutic Targeting of the Premetastatic Stage in Human Lung-to-Brain MetastasisCancer Research 2018; 78(17): 5124 doi: 10.1158/0008-5472.CAN-18-1022
79
Pieter H. du Preez, Kelly Breeds, N. Francois V. Burger, Hendrik W. Swiegers, J. Christoff Truter, Anna-Maria Botha. DNA Methylation and Demethylation Are Regulated by Functional DNA Methyltransferases and DnTET Enzymes in Diuraphis noxiaFrontiers in Genetics 2020; 11 doi: 10.3389/fgene.2020.00452
80
Kseniya Kovaleva, Olga Yarovaya, Konstantin Ponomarev, Sergey Cheresiz, Amirhossein Azimirad, Irina Chernyshova, Alexandra Zakharenko, Vasily Konev, Tatiana Khlebnikova, Evgenii Mozhaytsev, Evgenii Suslov, Dmitry Nilov, Vytas Švedas, Andrey Pokrovsky, Olga Lavrik, Nariman Salakhutdinov. Design, Synthesis, and Molecular Docking Study of New Tyrosyl-DNA Phosphodiesterase 1 (TDP1) Inhibitors Combining Resin Acids and Adamantane MoietiesPharmaceuticals 2021; 14(5): 422 doi: 10.3390/ph14050422
81
Yaqi Wang, Lifeng Yang, Jing Zhang, Menglong Zhou, Lijun Shen, Weijuan Deng, Liping Liang, Ran Hu, Wang Yang, Ye Yao, Hui Zhang, Zhen Zhang. Radiosensitization by irinotecan is attributed to G2/M phase arrest, followed by enhanced apoptosis, probably through the ATM/Chk/Cdc25C/Cdc2 pathway in p53-mutant colorectal cancer cells International Journal of Oncology 2018;  doi: 10.3892/ijo.2018.4514
82
Caroline Molinaro, Alain Martoriati, Lydie Pelinski, Katia Cailliau. Copper Complexes as Anticancer Agents Targeting Topoisomerases I and IICancers 2020; 12(10): 2863 doi: 10.3390/cancers12102863
83
Silpa Narayanan, Nehaben A. Gujarati, Jing-Quan Wang, Zhuo-Xun Wu, Jagadish Koya, Qingbin Cui, Vijaya L. Korlipara, Charles R. Ashby, Jr. Chen. The Novel Benzamide Derivative, VKNG-2, Restores the Efficacy of Chemotherapeutic Drugs in Colon Cancer Cell Lines by Inhibiting the ABCG2 TransporterInternational Journal of Molecular Sciences 2021; 22(5): 2463 doi: 10.3390/ijms22052463
84
Michèle Boisdron-Celle, Jean Philippe Metges, Olivier Capitain, Antoine Adenis, Jean Luc Raoul, Thierry Lecomte, You Heng Lam, Roger Faroux, Claude Masliah, Anne Lise Poirier, Virginie Berger, Alain Morel, Erick Gamelin. A multicenter phase II study of personalized FOLFIRI-cetuximab for safe dose intensificationSeminars in Oncology 2017; 44(1): 24 doi: 10.1053/j.seminoncol.2017.02.007
85
Zheng Zhang, Meng Gu, Zhongze Gu, Yan-Ru Lou. Role of Long Non-Coding RNA Polymorphisms in Cancer Chemotherapeutic ResponseJournal of Personalized Medicine 2021; 11(6): 513 doi: 10.3390/jpm11060513
86
Elke Cario. Toll-like receptors in the pathogenesis of chemotherapy-induced gastrointestinal toxicityCurrent Opinion in Supportive & Palliative Care 2016; 10(2): 157 doi: 10.1097/SPC.0000000000000202
87
Yihan Wu, Yanfen Cheng, Yuhan Yang, Di Wang, Xiaoqin Yang, Chaomei Fu, Jinming Zhang, Yichen Hu. Mechanisms of Gegen Qinlian Pill to ameliorate irinotecan-induced diarrhea investigated by the combination of serum pharmacochemistry and network pharmacologyJournal of Ethnopharmacology 2021; 276: 114200 doi: 10.1016/j.jep.2021.114200
88
Tetsuya Hamaguchi, Akihito Tsuji, Kensei Yamaguchi, Koji Takeda, Hiroyuki Uetake, Taito Esaki, Kenji Amagai, Daisuke Sakai, Hideo Baba, Masami Kimura, Yasuhiro Matsumura, Tetsuji Tsukamoto. A phase II study of NK012, a polymeric micelle formulation of SN-38, in unresectable, metastatic or recurrent colorectal cancer patientsCancer Chemotherapy and Pharmacology 2018; 82(6): 1021 doi: 10.1007/s00280-018-3693-6
89
Christine M. Heske, Arnulfo Mendoza, Leah D. Edessa, Joshua T. Baumgart, Sunmin Lee, Jane Trepel, David A. Proia, Len Neckers, Lee J. Helman. STA-8666, a novel HSP90 inhibitor/SN-38 drug conjugate, causes complete tumor regression in preclinical mouse models of pediatric sarcomaOncotarget 2016; 7(40): 65540 doi: 10.18632/oncotarget.11869
90
Bei Cheng, Peisheng Xu. Drug Repurposing in Cancer Therapy2020; : 335 doi: 10.1016/B978-0-12-819668-7.00013-0
91
Adrien Labriet, Elena De Mattia, Erika Cecchin, Éric Lévesque, Derek Jonker, Félix Couture, Angela Buonadonna, Mario D’Andrea, Lyne Villeneuve, Giuseppe Toffoli, Chantal Guillemette. Improved Progression-Free Survival in Irinotecan-Treated Metastatic Colorectal Cancer Patients Carrying the HNF1A Coding Variant p.I27LFrontiers in Pharmacology 2017; 8 doi: 10.3389/fphar.2017.00712
92
Roberto Puleio, Mariano Licciardi, Paola Varvarà, Cinzia Scialabba, Giovanni Cassata, Luca Cicero, Gennara Cavallaro, Gaetano Giammona. Effect of actively targeted copolymer coating on solid tumors eradication by gold nanorods-induced hyperthermiaInternational Journal of Pharmaceutics 2020; 587: 119641 doi: 10.1016/j.ijpharm.2020.119641
93
Anthony Dobi, Philippe Gasque, Pascale Guiraud, Jimmy Selambarom. Irinotecan (CPT-11) Canonical Anti-Cancer Drug Can also Modulate Antiviral and Pro-Inflammatory Responses of Primary Human Synovial FibroblastsCells 2021; 10(6): 1431 doi: 10.3390/cells10061431
94
Chunlei Xu, Xushan Tang, Yanli Qu, Saifuding Keyoumu, Ning Zhou, Yong Tang. UGT1A1 gene polymorphism is associated with toxicity and clinical efficacy of irinotecan-based chemotherapy in patients with advanced colorectal cancerCancer Chemotherapy and Pharmacology 2016; 78(1): 119 doi: 10.1007/s00280-016-3057-z
95
Yihan Wu, Di Wang, Xiaoqin Yang, Chaomei Fu, Liang Zou, Jinming Zhang. Traditional Chinese medicine Gegen Qinlian decoction ameliorates irinotecan chemotherapy-induced gut toxicity in miceBiomedicine & Pharmacotherapy 2019; 109: 2252 doi: 10.1016/j.biopha.2018.11.095
96
Beata Naumczuk, Marcin Górecki, Katarzyna Wiktorska, Magdalena Urbanowicz, Jerzy Sitkowski, Katarzyna Lubelska, Małgorzata Milczarek, Elżbieta Bednarek, Wojciech Bocian, Lech Kozerski. New camptothecin derivatives for generalized oncological chemotherapy: Synthesis, stereochemistry and biologyBioorganic & Medicinal Chemistry Letters 2021; 46: 128146 doi: 10.1016/j.bmcl.2021.128146
97
Ming-Hsien Lin, Chi-Feng Hung, Ching-Yun Hsu, Zih-Chan Lin, Jia-You Fang. Prodrugs in combination with nanocarriers as a strategy for promoting antitumoral efficiencyFuture Medicinal Chemistry 2019; 11(16): 2131 doi: 10.4155/fmc-2018-0388
98
Shi-Yu Liu, Ren-Yu Qu, Rong-Rong Li, Yao-Chao Yan, Yao Sun, Wen-Chao Yang, Guang-Fu Yang. An Activity-Based Fluorogenic Probe Enables Cellular and in Vivo Profiling of Carboxylesterase IsozymesAnalytical Chemistry 2020; 92(13): 9205 doi: 10.1021/acs.analchem.0c01554
99
Shan Lu, Obinna N. Obianom, Yong Ai. Novel cinnamaldehyde-based aspirin derivatives for the treatment of colorectal cancerBioorganic & Medicinal Chemistry Letters 2018; 28(17): 2869 doi: 10.1016/j.bmcl.2018.07.032
100
Yu Hou, Xiaoni Ai, Lin Zhao, Zhao Gao, Yujiang Wang, Yingyuang Lu, Pengfei Tu, Yong Jiang. An integrated biomimetic array chip for high-throughput co-culture of liver and tumor microtissues for advanced anticancer bioactivity screeningLab on a Chip 2020; 20(14): 2482 doi: 10.1039/D0LC00288G
101
Larissa Costa de Almeida, Anelize Bauermeister, Paula Rezende-Teixeira, Evelyne Alves dos Santos, Luiz Alberto Beraldo de Moraes, João Agostinho Machado-Neto, Leticia Veras Costa-Lotufo. Pradimicin-IRD exhibits antineoplastic effects by inducing DNA damage in colon cancer cellsBiochemical Pharmacology 2019; 168: 38 doi: 10.1016/j.bcp.2019.06.016
102
Daniel C. Pan, Vinu Krishnan, Alyssa K. Salinas, Jayoung Kim, Tao Sun, Sagi Ravid, Kevin Peng, Debra Wu, Md Nurunnabi, Jeffery A. Nelson, Zachary Niziolek, Junling Guo, Samir Mitragotri. Hyaluronic a cid–doxorubicin nanoparticles for targeted treatment of colorectal cancer Bioengineering & Translational Medicine 2021; 6(1) doi: 10.1002/btm2.10166
103
Chen Shaojun, Hua Li, Huang Haixin, Li Guisheng. Expression of Topoisomerase 1 and carboxylesterase 2 correlates with irinotecan treatment response in metastatic colorectal cancerCancer Biology & Therapy 2018; 19(3): 153 doi: 10.1080/15384047.2017.1414754
104
Sylvia Chen, Natalia Sutiman, Clara Zhenxian Zhang, Yingnan Yu, Shirley Lam, Chiea Chuen Khor, Balram Chowbay. Pharmacogenetics of irinotecan, doxorubicin and docetaxel transporters in Asian and Caucasian cancer patients: a comparative reviewDrug Metabolism Reviews 2016; 48(4): 502 doi: 10.1080/03602532.2016.1226896